ISB News

ISB’s Summer Interns Brightest of the Bright

Photo above: ISB’s high school interns presented their research.

Every summer, ISB and ISB’s Center for Systems Biology welcome undergraduate and high school students for internships in our labs. Each student is paired with a mentor and works on research actually taking place in the respective lab. The internships are extremely competitive and we see some of the brightest young minds from across the country.

undergrad_leehood2

Bijou Basu, from Washington University in St. Louis, presented her research poster in a rare opportunity to meet with ISB President Dr. Lee Hood.

 

Read about their experiences at their group web sites:

Undergraduate interns site

High school interns site

undgrad_group

ISB’s undergraduate interns.

Learn more about ISB’s internship programs

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.